

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.75885727 |
| 2 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.99308086 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.95678916 |
| 4 | microglial cell activation (GO:0001774) | 5.82779525 |
| 5 | macrophage activation involved in immune response (GO:0002281) | 5.69701808 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.59597687 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.59597687 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.59597687 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.59597687 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.59597687 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.59597687 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.43803321 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 5.15675674 |
| 14 | respiratory burst (GO:0045730) | 4.89368900 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.85699415 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.67372531 |
| 17 | positive regulation of antigen processing and presentation (GO:0002579) | 4.66272329 |
| 18 | macrophage activation (GO:0042116) | 4.61608315 |
| 19 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.60466560 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.60010286 |
| 21 | granulocyte activation (GO:0036230) | 4.44437502 |
| 22 | myeloid cell activation involved in immune response (GO:0002275) | 4.34963548 |
| 23 | neutrophil activation (GO:0042119) | 4.29722088 |
| 24 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.26411458 |
| 25 | response to peptidoglycan (GO:0032494) | 4.24686155 |
| 26 | detection of other organism (GO:0098543) | 4.19647922 |
| 27 | detection of bacterium (GO:0016045) | 4.07835288 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 4.04827351 |
| 29 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.01906916 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.99557868 |
| 31 | regulation of antigen processing and presentation (GO:0002577) | 3.99163902 |
| 32 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.94090583 |
| 33 | regulation of hypersensitivity (GO:0002883) | 3.93404265 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.88445663 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.83080539 |
| 36 | negative regulation of granulocyte differentiation (GO:0030853) | 3.78983634 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.77629563 |
| 38 | T-helper 1 type immune response (GO:0042088) | 3.74770041 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.74538980 |
| 40 | positive regulation of leukocyte degranulation (GO:0043302) | 3.74070729 |
| 41 | myeloid dendritic cell activation (GO:0001773) | 3.69746623 |
| 42 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.68443316 |
| 43 | positive regulation of interferon-beta production (GO:0032728) | 3.67442213 |
| 44 | myeloid dendritic cell differentiation (GO:0043011) | 3.64192368 |
| 45 | myeloid leukocyte activation (GO:0002274) | 3.63901872 |
| 46 | positive regulation of chemokine secretion (GO:0090197) | 3.63209525 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62031276 |
| 48 | response to host immune response (GO:0052572) | 3.60305279 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.60305279 |
| 50 | regulation of monocyte chemotaxis (GO:0090025) | 3.58711430 |
| 51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.55376289 |
| 52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.55271047 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.55157264 |
| 54 | cellular response to interferon-gamma (GO:0071346) | 3.54651459 |
| 55 | cellular response to interferon-beta (GO:0035458) | 3.54520108 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 3.54008812 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.53751155 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53751155 |
| 59 | cellular response to exogenous dsRNA (GO:0071360) | 3.52302248 |
| 60 | cellular response to zinc ion (GO:0071294) | 3.52278907 |
| 61 | response to muramyl dipeptide (GO:0032495) | 3.49954767 |
| 62 | regulation of B cell differentiation (GO:0045577) | 3.48294370 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.45603463 |
| 64 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.45539111 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.42926503 |
| 66 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42527106 |
| 67 | negative regulation of mast cell activation (GO:0033004) | 3.41285309 |
| 68 | positive regulation of mast cell degranulation (GO:0043306) | 3.41175964 |
| 69 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.41175964 |
| 70 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41110074 |
| 71 | positive regulation of type 2 immune response (GO:0002830) | 3.40606744 |
| 72 | defense response to protozoan (GO:0042832) | 3.40468230 |
| 73 | pinocytosis (GO:0006907) | 3.38339803 |
| 74 | positive regulation of interleukin-12 production (GO:0032735) | 3.36512993 |
| 75 | B cell mediated immunity (GO:0019724) | 3.34980894 |
| 76 | mature B cell differentiation involved in immune response (GO:0002313) | 3.34785201 |
| 77 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32435291 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31907485 |
| 79 | dendritic cell differentiation (GO:0097028) | 3.31778323 |
| 80 | mast cell activation (GO:0045576) | 3.31079545 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 3.30214404 |
| 82 | I-kappaB phosphorylation (GO:0007252) | 3.29661149 |
| 83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.29427149 |
| 84 | response to interferon-gamma (GO:0034341) | 3.24195674 |
| 85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.24014423 |
| 86 | cellular extravasation (GO:0045123) | 3.23799903 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23489931 |
| 88 | response to host (GO:0075136) | 3.23489931 |
| 89 | response to host defenses (GO:0052200) | 3.23489931 |
| 90 | eosinophil chemotaxis (GO:0048245) | 3.22971679 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.20595919 |
| 92 | negative regulation of B cell proliferation (GO:0030889) | 3.20048554 |
| 93 | leukocyte mediated cytotoxicity (GO:0001909) | 3.18440585 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17691287 |
| 95 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.17691287 |
| 96 | cellular response to type I interferon (GO:0071357) | 3.14544440 |
| 97 | type I interferon signaling pathway (GO:0060337) | 3.14544440 |
| 98 | phagocytosis, engulfment (GO:0006911) | 3.13955992 |
| 99 | regulation of gamma-delta T cell activation (GO:0046643) | 3.13480001 |
| 100 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.12231213 |
| 101 | response to type I interferon (GO:0034340) | 3.11781440 |
| 102 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.10670371 |
| 103 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.10557795 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10338203 |
| 105 | germinal center formation (GO:0002467) | 3.09101848 |
| 106 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.07290452 |
| 107 | positive regulation of lymphocyte migration (GO:2000403) | 3.07091294 |
| 108 | monocyte chemotaxis (GO:0002548) | 3.06716390 |
| 109 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06175906 |
| 110 | response to protozoan (GO:0001562) | 3.04800598 |
| 111 | negative regulation of phagocytosis (GO:0050765) | 3.03127343 |
| 112 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.02497862 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00065990 |
| 114 | T cell costimulation (GO:0031295) | 2.99718726 |
| 115 | regulation of T cell tolerance induction (GO:0002664) | 2.98622114 |
| 116 | mature B cell differentiation (GO:0002335) | 2.98075552 |
| 117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.97834880 |
| 118 | negative regulation of interleukin-17 production (GO:0032700) | 2.97569529 |
| 119 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.97434341 |
| 120 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.96170796 |
| 121 | positive regulation of B cell mediated immunity (GO:0002714) | 2.95916164 |
| 122 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.95916164 |
| 123 | lymphocyte costimulation (GO:0031294) | 2.95265805 |
| 124 | positive thymic T cell selection (GO:0045059) | 2.95217964 |
| 125 | regulation of germinal center formation (GO:0002634) | 2.94482628 |
| 126 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.93137038 |
| 127 | glycosphingolipid catabolic process (GO:0046479) | 2.93130684 |
| 128 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92825049 |
| 129 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.91671032 |
| 130 | regulation of tolerance induction (GO:0002643) | 2.91510293 |
| 131 | T cell migration (GO:0072678) | 2.88851553 |
| 132 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86565606 |
| 133 | regulation of interleukin-12 production (GO:0032655) | 2.86441303 |
| 134 | histamine secretion (GO:0001821) | 2.86215122 |
| 135 | eosinophil migration (GO:0072677) | 2.85106848 |
| 136 | negative regulation of growth of symbiont in host (GO:0044130) | 2.85076520 |
| 137 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.85076520 |
| 138 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.85076520 |
| 139 | regulation of growth of symbiont in host (GO:0044126) | 2.85076520 |
| 140 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85013728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.30391722 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.67658512 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.53447459 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 5.24606861 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.52598154 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.52532857 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.97634360 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.77575937 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75024414 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.56086230 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.08500595 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.01378762 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.96698522 |
| 14 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90387545 |
| 15 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.89126740 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84429808 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.60721784 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.53455819 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52288298 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21298058 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21095487 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19458320 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11589487 |
| 24 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.11189326 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09684956 |
| 26 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09495667 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06257159 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.01511208 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.98651005 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.96961577 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95472927 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93876863 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93532710 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90636460 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83840939 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82084701 |
| 37 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74715864 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74087295 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.72427900 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70226371 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69258092 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68805604 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67349602 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61864343 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.61580038 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61240582 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57223429 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54586355 |
| 49 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49435061 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38759318 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.38503516 |
| 52 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38105817 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37210449 |
| 54 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36257109 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35469654 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29599226 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26522037 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.26303456 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24958988 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24213039 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22354364 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22046489 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20806719 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20637006 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19147227 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18344945 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14120536 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11632351 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10802645 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05055809 |
| 71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04868202 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04521459 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03508954 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00365458 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99852001 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93041523 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92660821 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92612221 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91860824 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91831609 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89461057 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88169002 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 0.87667755 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87047988 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83243499 |
| 86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83007360 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79181034 |
| 88 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.79080273 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78424135 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78353969 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.76333808 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75681115 |
| 93 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.74974646 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.73994903 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72653588 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71991101 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69876302 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69177668 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67009850 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66826853 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.66804643 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64624484 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.64201446 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.62605744 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.60913583 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.59976305 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57480060 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.53377824 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.50488519 |
| 110 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.49949205 |
| 111 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.48477204 |
| 112 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.47771264 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.46980654 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.46889949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.74650675 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 3.89760873 |
| 3 | MP0006082_CNS_inflammation | 3.52727840 |
| 4 | MP0003436_decreased_susceptibility_to | 3.45093764 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.33575303 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.31617513 |
| 7 | MP0002419_abnormal_innate_immunity | 3.25703019 |
| 8 | MP0005671_abnormal_response_to | 3.24679347 |
| 9 | MP0003303_peritoneal_inflammation | 3.10255285 |
| 10 | * MP0001800_abnormal_humoral_immune | 2.99680025 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.99323696 |
| 12 | MP0001790_abnormal_immune_system | 2.98844387 |
| 13 | MP0005387_immune_system_phenotype | 2.98844387 |
| 14 | MP0009785_altered_susceptibility_to | 2.84289824 |
| 15 | MP0005025_abnormal_response_to | 2.82565333 |
| 16 | * MP0002723_abnormal_immune_serum | 2.71620307 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.70035407 |
| 18 | MP0000685_abnormal_immune_system | 2.60118637 |
| 19 | * MP0001819_abnormal_immune_cell | 2.49386726 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.48558601 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.48228503 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.37833608 |
| 23 | MP0003724_increased_susceptibility_to | 2.10212905 |
| 24 | MP0001853_heart_inflammation | 2.05301749 |
| 25 | MP0004510_myositis | 2.01774998 |
| 26 | MP0002405_respiratory_system_inflammati | 1.88454485 |
| 27 | * MP0000716_abnormal_immune_system | 1.87843093 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.87507939 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.85219608 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.85001516 |
| 31 | MP0009840_abnormal_foam_cell | 1.81907073 |
| 32 | MP0003075_altered_response_to | 1.81847189 |
| 33 | * MP0002398_abnormal_bone_marrow | 1.76638979 |
| 34 | MP0003690_abnormal_glial_cell | 1.74884362 |
| 35 | MP0005310_abnormal_salivary_gland | 1.73095024 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.71402230 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.65651354 |
| 38 | MP0000343_altered_response_to | 1.65555970 |
| 39 | MP0008469_abnormal_protein_level | 1.65140172 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.56410599 |
| 41 | MP0002006_tumorigenesis | 1.52156027 |
| 42 | * MP0002429_abnormal_blood_cell | 1.50743690 |
| 43 | MP0009764_decreased_sensitivity_to | 1.42703518 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.41438905 |
| 45 | MP0002722_abnormal_immune_system | 1.41384418 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.39899634 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.37014512 |
| 48 | MP0005166_decreased_susceptibility_to | 1.36829720 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.34953225 |
| 50 | MP0004947_skin_inflammation | 1.33498459 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.33066711 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.29397966 |
| 53 | MP0000604_amyloidosis | 1.24385049 |
| 54 | MP0000858_altered_metastatic_potential | 1.23879343 |
| 55 | MP0003448_altered_tumor_morphology | 1.22755435 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.15671281 |
| 57 | MP0005451_abnormal_body_composition | 1.12574369 |
| 58 | MP0004883_abnormal_blood_vessel | 1.08066868 |
| 59 | MP0000249_abnormal_blood_vessel | 0.97106942 |
| 60 | MP0002736_abnormal_nociception_after | 0.95124581 |
| 61 | MP0005174_abnormal_tail_pigmentation | 0.94403390 |
| 62 | MP0005164_abnormal_response_to | 0.92677296 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 0.92213395 |
| 64 | MP0003763_abnormal_thymus_physiology | 0.91327104 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 0.88785003 |
| 66 | MP0000015_abnormal_ear_pigmentation | 0.87121517 |
| 67 | MP0002933_joint_inflammation | 0.86848181 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.86252001 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.86021471 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 0.86021471 |
| 71 | MP0001663_abnormal_digestive_system | 0.84886863 |
| 72 | MP0010307_abnormal_tumor_latency | 0.84465329 |
| 73 | MP0003828_pulmonary_edema | 0.81599266 |
| 74 | MP0001851_eye_inflammation | 0.81406228 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.80429661 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.78327783 |
| 77 | MP0005390_skeleton_phenotype | 0.78119910 |
| 78 | MP0009763_increased_sensitivity_to | 0.77191897 |
| 79 | MP0000569_abnormal_digit_pigmentation | 0.76486314 |
| 80 | MP0001873_stomach_inflammation | 0.75952232 |
| 81 | MP0000920_abnormal_myelination | 0.75068814 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.73833899 |
| 83 | MP0002254_reproductive_system_inflammat | 0.73816244 |
| 84 | MP0002928_abnormal_bile_duct | 0.71737669 |
| 85 | MP0008260_abnormal_autophagy | 0.71501704 |
| 86 | MP0004808_abnormal_hematopoietic_stem | 0.71434906 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.70128566 |
| 88 | MP0008873_increased_physiological_sensi | 0.69760662 |
| 89 | MP0001542_abnormal_bone_strength | 0.69022119 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.68922681 |
| 91 | MP0003045_fibrosis | 0.68602318 |
| 92 | MP0001915_intracranial_hemorrhage | 0.66972722 |
| 93 | MP0001968_abnormal_touch/_nociception | 0.66393383 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.65235736 |
| 95 | MP0008004_abnormal_stomach_pH | 0.64848910 |
| 96 | MP0003279_aneurysm | 0.64712395 |
| 97 | MP0003866_abnormal_defecation | 0.64636325 |
| 98 | MP0005165_increased_susceptibility_to | 0.64441262 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.64037760 |
| 100 | MP0002132_abnormal_respiratory_system | 0.63392652 |
| 101 | MP0003795_abnormal_bone_structure | 0.62523202 |
| 102 | MP0009278_abnormal_bone_marrow | 0.62408057 |
| 103 | MP0000490_abnormal_crypts_of | 0.61576008 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.58489884 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.58294201 |
| 106 | MP0006054_spinal_hemorrhage | 0.58217534 |
| 107 | MP0002090_abnormal_vision | 0.56602456 |
| 108 | MP0005535_abnormal_body_temperature | 0.56223928 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.54356334 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.53623413 |
| 111 | MP0005647_abnormal_sex_gland | 0.52661563 |
| 112 | MP0008874_decreased_physiological_sensi | 0.52404356 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52285076 |
| 114 | MP0000371_diluted_coat_color | 0.51738858 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.50802994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.36253603 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.98222169 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.71396396 |
| 4 | Glomerulonephritis (HP:0000099) | 6.01742214 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.58955274 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.61507096 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.61507096 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.61507096 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.42827793 |
| 10 | Agnosia (HP:0010524) | 4.38428684 |
| 11 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.38179447 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12352544 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.11302352 |
| 14 | Recurrent skin infections (HP:0001581) | 4.11126843 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 4.08761174 |
| 16 | Complement deficiency (HP:0004431) | 4.08596014 |
| 17 | Disinhibition (HP:0000734) | 4.07340547 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.02581798 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.92648756 |
| 20 | Axonal loss (HP:0003447) | 3.90007206 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.78640413 |
| 22 | Myositis (HP:0100614) | 3.76829349 |
| 23 | Abnormality of complement system (HP:0005339) | 3.71665379 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.58937101 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53029742 |
| 26 | Obstructive lung disease (HP:0006536) | 3.53029742 |
| 27 | Nephritis (HP:0000123) | 3.44132527 |
| 28 | Recurrent viral infections (HP:0004429) | 3.42695563 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.36177499 |
| 30 | Cellulitis (HP:0100658) | 3.35324085 |
| 31 | Recurrent fungal infections (HP:0002841) | 3.33724059 |
| 32 | Loss of speech (HP:0002371) | 3.32516532 |
| 33 | Vasculitis (HP:0002633) | 3.24126863 |
| 34 | Colitis (HP:0002583) | 3.21748839 |
| 35 | Meningitis (HP:0001287) | 3.14976259 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.06512211 |
| 37 | Gingivitis (HP:0000230) | 3.05901814 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.03060324 |
| 39 | Orchitis (HP:0100796) | 2.98538986 |
| 40 | Purpura (HP:0000979) | 2.88140543 |
| 41 | Hematochezia (HP:0002573) | 2.87676644 |
| 42 | Recurrent pneumonia (HP:0006532) | 2.85394314 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.81445167 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.80424750 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78531320 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78531320 |
| 47 | Optic neuritis (HP:0100653) | 2.76228999 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.76228999 |
| 49 | Pustule (HP:0200039) | 2.75030957 |
| 50 | Osteomyelitis (HP:0002754) | 2.74661790 |
| 51 | Upper motor neuron abnormality (HP:0002127) | 2.72666342 |
| 52 | Chronic otitis media (HP:0000389) | 2.69045417 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.66422101 |
| 54 | IgM deficiency (HP:0002850) | 2.62396211 |
| 55 | Encephalitis (HP:0002383) | 2.61798421 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.60537669 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.60023478 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.60023478 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.59839062 |
| 60 | Petechiae (HP:0000967) | 2.59252345 |
| 61 | Chest pain (HP:0100749) | 2.57347006 |
| 62 | Periodontitis (HP:0000704) | 2.57258029 |
| 63 | Stomatitis (HP:0010280) | 2.57151763 |
| 64 | Recurrent lower respiratory tract infections (HP:0002783) | 2.54773190 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.54144832 |
| 66 | Increased serum ferritin (HP:0003281) | 2.51642703 |
| 67 | Chronic diarrhea (HP:0002028) | 2.50434198 |
| 68 | Restrictive lung disease (HP:0002091) | 2.50118435 |
| 69 | Gangrene (HP:0100758) | 2.49189526 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.47691152 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.46267541 |
| 72 | Polyneuropathy (HP:0001271) | 2.44130213 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.43680207 |
| 74 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.42471307 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41524381 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41524381 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41524381 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.41140076 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.40079776 |
| 80 | Pathologic fracture (HP:0002756) | 2.37327009 |
| 81 | Increased IgM level (HP:0003496) | 2.36737381 |
| 82 | Pulmonary embolism (HP:0002204) | 2.35220677 |
| 83 | Thick nail (HP:0001805) | 2.33481610 |
| 84 | Epistaxis (HP:0000421) | 2.29983930 |
| 85 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.29000142 |
| 86 | Prostate neoplasm (HP:0100787) | 2.27791116 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.26267584 |
| 88 | T lymphocytopenia (HP:0005403) | 2.23265192 |
| 89 | Amyloidosis (HP:0011034) | 2.22794228 |
| 90 | Thrombocytosis (HP:0001894) | 2.21987807 |
| 91 | Inappropriate behavior (HP:0000719) | 2.21488205 |
| 92 | Leukocytosis (HP:0001974) | 2.20744727 |
| 93 | Eosinophilia (HP:0001880) | 2.20552828 |
| 94 | Panhypogammaglobulinemia (HP:0003139) | 2.19938471 |
| 95 | Myocardial infarction (HP:0001658) | 2.18548622 |
| 96 | Abnormality of T cell number (HP:0011839) | 2.16333927 |
| 97 | Increased IgE level (HP:0003212) | 2.14308969 |
| 98 | Memory impairment (HP:0002354) | 2.14298159 |
| 99 | Recurrent bronchitis (HP:0002837) | 2.12445363 |
| 100 | Urticaria (HP:0001025) | 2.12039122 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.11206233 |
| 102 | Skin rash (HP:0000988) | 2.09984547 |
| 103 | Abnormality of the prostate (HP:0008775) | 2.09781586 |
| 104 | Glomerulopathy (HP:0100820) | 2.07907001 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07639019 |
| 106 | Pulmonary fibrosis (HP:0002206) | 2.07255930 |
| 107 | Gingival bleeding (HP:0000225) | 2.07098550 |
| 108 | Lymphopenia (HP:0001888) | 2.05712887 |
| 109 | Sepsis (HP:0100806) | 2.02418663 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01790254 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.00240290 |
| 112 | Retinal atrophy (HP:0001105) | 1.99611522 |
| 113 | Abnormality of B cell number (HP:0010975) | 1.99302165 |
| 114 | Spondylolisthesis (HP:0003302) | 1.99256621 |
| 115 | Acrocyanosis (HP:0001063) | 1.99056763 |
| 116 | Recurrent sinusitis (HP:0011108) | 1.98455933 |
| 117 | Arterial thrombosis (HP:0004420) | 1.98133743 |
| 118 | Thyroiditis (HP:0100646) | 1.94700746 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.94420360 |
| 120 | Mutism (HP:0002300) | 1.92521388 |
| 121 | Hemoptysis (HP:0002105) | 1.91961637 |
| 122 | Emphysema (HP:0002097) | 1.91032595 |
| 123 | Osteolytic defects of the hand bones (HP:0009699) | 1.89312960 |
| 124 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89312960 |
| 125 | Personality changes (HP:0000751) | 1.88468136 |
| 126 | Arthralgia (HP:0002829) | 1.88188541 |
| 127 | Thoracic kyphosis (HP:0002942) | 1.84253321 |
| 128 | Poor head control (HP:0002421) | 1.83270097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.85259938 |
| 2 | TGFBR2 | 4.39227556 |
| 3 | RIPK4 | 4.06251935 |
| 4 | MAP3K14 | 3.83064870 |
| 5 | MAP4K1 | 3.43320829 |
| 6 | TYK2 | 3.27628507 |
| 7 | IRAK4 | 3.21927430 |
| 8 | CSF1R | 2.81908287 |
| 9 | TBK1 | 2.70746202 |
| 10 | IRAK3 | 2.67938725 |
| 11 | KIT | 2.56340957 |
| 12 | GRK7 | 2.55592209 |
| 13 | CDK19 | 2.17848925 |
| 14 | IKBKB | 2.05980051 |
| 15 | SYK | 1.93256942 |
| 16 | JAK1 | 1.87478419 |
| 17 | ERN1 | 1.86298444 |
| 18 | NEK9 | 1.81218871 |
| 19 | BTK | 1.68817533 |
| 20 | IKBKE | 1.64105611 |
| 21 | STK10 | 1.63010492 |
| 22 | LYN | 1.62188250 |
| 23 | JAK3 | 1.60646666 |
| 24 | MAP3K13 | 1.59893792 |
| 25 | TXK | 1.58859073 |
| 26 | TAOK2 | 1.57464839 |
| 27 | ZAP70 | 1.56767128 |
| 28 | MATK | 1.50001943 |
| 29 | TEC | 1.49127605 |
| 30 | PRPF4B | 1.47156512 |
| 31 | CSK | 1.40859268 |
| 32 | MAP3K11 | 1.40858869 |
| 33 | CLK1 | 1.37382426 |
| 34 | HCK | 1.36461480 |
| 35 | TNK2 | 1.36299691 |
| 36 | FES | 1.31633843 |
| 37 | TAOK1 | 1.21587624 |
| 38 | LCK | 1.19683329 |
| 39 | ITK | 1.15074088 |
| 40 | MAP3K12 | 1.14930430 |
| 41 | JAK2 | 1.07215881 |
| 42 | MOS | 1.06185333 |
| 43 | PDK2 | 1.03244095 |
| 44 | TAOK3 | 1.03191920 |
| 45 | TLK1 | 0.99284961 |
| 46 | CHUK | 0.98151324 |
| 47 | BMPR2 | 0.96398456 |
| 48 | PIM2 | 0.95868273 |
| 49 | MARK3 | 0.92778939 |
| 50 | MAP2K3 | 0.91270394 |
| 51 | YES1 | 0.89838777 |
| 52 | SIK3 | 0.89233859 |
| 53 | ADRBK2 | 0.86625611 |
| 54 | EIF2AK2 | 0.84479284 |
| 55 | SCYL2 | 0.84414579 |
| 56 | TESK2 | 0.79156882 |
| 57 | PIM1 | 0.78820859 |
| 58 | MAPK12 | 0.78405877 |
| 59 | MST4 | 0.77135388 |
| 60 | PRKCD | 0.73135564 |
| 61 | MAP3K1 | 0.70956558 |
| 62 | PDK1 | 0.69803359 |
| 63 | DAPK3 | 0.68452707 |
| 64 | MAP3K5 | 0.68442955 |
| 65 | LRRK2 | 0.67402715 |
| 66 | FLT3 | 0.67296043 |
| 67 | GRK5 | 0.64841000 |
| 68 | SIK2 | 0.63870489 |
| 69 | CDC42BPA | 0.62496471 |
| 70 | NME2 | 0.62038731 |
| 71 | EIF2AK3 | 0.61594514 |
| 72 | DDR2 | 0.61372975 |
| 73 | MAPK15 | 0.60003665 |
| 74 | ARAF | 0.58779595 |
| 75 | EPHB1 | 0.58630251 |
| 76 | FGR | 0.58543937 |
| 77 | GRK6 | 0.58052502 |
| 78 | MAPKAPK2 | 0.55555602 |
| 79 | KDR | 0.54186282 |
| 80 | RPS6KA4 | 0.52167297 |
| 81 | ABL1 | 0.51315858 |
| 82 | CAMKK2 | 0.50505064 |
| 83 | FGFR3 | 0.49910626 |
| 84 | MST1R | 0.49757185 |
| 85 | MAPK4 | 0.49691205 |
| 86 | PRKCQ | 0.48821226 |
| 87 | EGFR | 0.47916978 |
| 88 | RPS6KA6 | 0.46204047 |
| 89 | CDK4 | 0.42388541 |
| 90 | MAPK7 | 0.41772887 |
| 91 | STK4 | 0.41698840 |
| 92 | IGF1R | 0.40901461 |
| 93 | PKN2 | 0.40806910 |
| 94 | TRPM7 | 0.40567957 |
| 95 | PBK | 0.40368096 |
| 96 | CDK6 | 0.40293616 |
| 97 | PAK4 | 0.39006991 |
| 98 | ACVR1B | 0.38246411 |
| 99 | RPS6KL1 | 0.37663406 |
| 100 | RPS6KC1 | 0.37663406 |
| 101 | ABL2 | 0.37436162 |
| 102 | TSSK6 | 0.37397624 |
| 103 | PDPK1 | 0.36741356 |
| 104 | CAMK1D | 0.35964155 |
| 105 | MAP2K6 | 0.34344063 |
| 106 | CAMKK1 | 0.33534377 |
| 107 | PKN1 | 0.33384891 |
| 108 | PIK3CG | 0.33108500 |
| 109 | RPS6KA2 | 0.32695292 |
| 110 | DAPK1 | 0.32290355 |
| 111 | FYN | 0.29968028 |
| 112 | HIPK2 | 0.29456619 |
| 113 | STK24 | 0.28062302 |
| 114 | IRAK2 | 0.26463685 |
| 115 | VRK1 | 0.26061458 |
| 116 | ILK | 0.25535950 |
| 117 | MAP3K3 | 0.23536409 |
| 118 | BMX | 0.23228297 |
| 119 | NEK6 | 0.22945693 |
| 120 | MAP3K8 | 0.21977295 |
| 121 | PAK1 | 0.21756828 |
| 122 | CCNB1 | 0.20953351 |
| 123 | IRAK1 | 0.20908732 |
| 124 | DAPK2 | 0.20536334 |
| 125 | INSR | 0.19034112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.08614379 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.18868430 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.05326872 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.01780766 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.74658489 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.73896212 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.65586298 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.65225565 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.52341542 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.28964683 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26059918 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.21479107 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.05109991 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95475464 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.95368166 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94709293 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.93957282 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.91798433 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.91784252 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87428461 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85239447 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.80352786 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.75070565 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64616249 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64225794 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63334092 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62023010 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.59453480 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.59416933 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.57762474 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.57329183 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56330355 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54416712 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53924890 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.51694159 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.33882361 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30887078 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29395842 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24282433 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.20150335 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19749324 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.16596813 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14944744 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.09941360 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06716811 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05448693 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04760789 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.00619491 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91274844 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89201515 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88675282 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87222895 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86985834 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84736864 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81934203 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.81220320 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81186349 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79246499 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76819055 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76122687 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75472171 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72821979 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.72599268 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68740060 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67562804 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63192286 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59084620 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56919113 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55528909 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.48830083 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46745625 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41814535 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41220152 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.40758868 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32321698 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31095704 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30690286 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30189584 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29890655 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29755233 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29479423 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29396779 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29210853 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28468689 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27727838 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.25587541 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24346117 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24247738 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23587717 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23342634 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23250597 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20861771 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.20051900 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18640840 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17740765 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17092511 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.16944894 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16691132 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14935746 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14589087 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.14182698 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.13814480 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.12730739 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12118549 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11388506 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11295460 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.11001618 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10109151 |
| 109 | Proteasome_Homo sapiens_hsa03050 | 0.05458980 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.05131085 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.01646996 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.00303776 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0255224 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0240815 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0038760 |

